Skip to nav Skip to content

2166 article(s) found

Moffitt Hosts Florida’s First-Ever Mobile Lung Screening Event

In 2023, less than 3% of eligible Floridians received low dose CT scans to detect lung cancer

Chief Pathology Officer James Pepoon presented Retired Air Force Major Barney Morris, a prostate cancer survivor and Moffitt advocate, with a plaque in appreciation for his 20 years of service.

Moffitt Thanks Veterans for Their Service

Moffitt’s 8th annual Veterans Day Ceremony honors retired Air Force major and prostate cancer survivor

Candid photos of Dave Coulier from Facebook

Dave Coulier of ‘Full House’ Diagnosed With Non-Hodgkin Lymphoma

Golf ball-size swelling in his groin area was first sign of concern

graphic image of a brain with a tumor and cancer cells

New Treatment Combines Electric Fields and Immunotherapy to Improve Survival for Glioblastoma Patients

Study shows promising results for patients with inoperable tumors, offering hope for better outcomes in one of the most aggressive forms of brain cancer

Newly Approved CAR T-Cell Therapy Gives Acute Lymphoblastic Leukemia a New Personalized Option

Novel design and tumor-guided dosing may reduce side effects while maintaining encouraging efficacy

AutoNation Distributes Totes for Hope to Patients at Moffitt Cancer Center

Organization is also presenting sponsor for Miles for Moffitt on Nov. 23

graphic of T cells attacking a tumor

Newly Approved Cell Therapy Afami-Cel Shows Long-Term Tumor Control in Synovial Sarcoma

Phase 2 clinical trial data suggests the engineered T cells can stay active in the body for more than three years

medical illustration of lungs with cancer cells floating around. also includes the Moffitt and SITC logos

New Cancer Vaccine May Boost Immunotherapy in Treating Lung Cancer

Phase 2 trial results suggest IO102-IO103 combined with pembrolizumab may enhance response rates in advanced lung cancer

A Novel Class of Therapeutic Biologics Shows Promise for HPV-Related Head and Neck Cancer

Combining two treatments may improve outcomes for patients with HPV 16–positive disease